
HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
Keywords: لیپاتینیب; Breast cancer; Human epidermal growth factor receptor 2; Lapatinib; Targeted therapy; Trastuzumab